These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9159420)

  • 1. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission.
    Carmina E; Lobo RA
    Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
    Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
    Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P; Mauri M; Gutierrez M
    Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients.
    Venturoli S; Ravaioli B; Bagnoli A; Colombo FM; Macrelli S; Iadarola I; Vianello F; Mancini F; Flamigni C
    Eur J Contracept Reprod Health Care; 1998 Mar; 3(1):29-33. PubMed ID: 9678070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Beigi A; Sobhi A; Zarrinkoub F
    Int J Gynaecol Obstet; 2004 Oct; 87(1):29-33. PubMed ID: 15464773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
    Sert M; Tetiker T; Kirim S
    Acta Med Okayama; 2003 Apr; 57(2):73-6. PubMed ID: 12866746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
    Kelekci KH; Kelekci S; Yengel I; Gul S; Yilmaz B
    J Dermatolog Treat; 2012 Jun; 23(3):177-83. PubMed ID: 21254871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for a non-androgenic anovulant in the management of hirsutism.
    McKenna TJ; Cunningham SK
    Ir J Med Sci; 1991 Jul; 160(7):194-6. PubMed ID: 1757211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
    Gollnick H; Albring M; Brill K
    Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
    Keleştimur F; Sahin Y
    Fertil Steril; 1998 Jan; 69(1):66-9. PubMed ID: 9457935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate for hirsutism.
    Van der Spuy ZM; le Roux PA
    Cochrane Database Syst Rev; 2003; 2003(4):CD001125. PubMed ID: 14583927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
    Chung JP; Yiu AK; Chung TK; Chan SS
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.